Listed

Nuo Therapeutics, Inc.: Form 10-Q for the period ended Jun 30, 2017

Filed with the SEC on Aug 14, 2017 and accepted by EDGAR at Aug 11, 2017, 18:50 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2017-04-01 to 2017-06-30$188.6kus-gaap:Revenues
Revenue6 months2017-01-01 to 2017-06-30$361.3kus-gaap:Revenues
Cost of revenue3 months2017-04-01 to 2017-06-30$277.4kus-gaap:CostOfRevenue
Cost of revenue6 months2017-01-01 to 2017-06-30$547.5kus-gaap:CostOfRevenue
Gross profit3 months2017-04-01 to 2017-06-30−$88.8kus-gaap:GrossProfit
Gross profit6 months2017-01-01 to 2017-06-30−$186.1kus-gaap:GrossProfit
Research and development3 months2017-04-01 to 2017-06-30$309.5kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2017-01-01 to 2017-06-30$708.9kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2017-04-01 to 2017-06-30−$3.9mus-gaap:OperatingIncomeLoss
Operating income6 months2017-01-01 to 2017-06-30−$5.6mus-gaap:OperatingIncomeLoss
Net income3 months2017-04-01 to 2017-06-30−$3.9mus-gaap:NetIncomeLoss
Net income6 months2017-01-01 to 2017-06-30−$5.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-04-01 to 2017-06-30−$0.39us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2017-01-01 to 2017-06-30−$0.56us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-04-01 to 2017-06-30−$0.39us-gaap:EarningsPerShareBasic
Basic EPS6 months2017-01-01 to 2017-06-30−$0.56us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2017-04-01 to 2017-06-309,927,112 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2017-01-01 to 2017-06-309,927,112 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Cash and equivalentsAt period end2017-06-30$331.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-06-30$900.0kus-gaap:AssetsCurrent
Total assetsAt period end2017-06-30$8.8mus-gaap:Assets
Current liabilitiesAt period end2017-06-30$1.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-06-30$1.9mus-gaap:Liabilities
Shareholders' equityAt period end2017-06-30$6.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-17-014570. Last ingested by Listed: Nov 14, 2026, 23:44 ET. Listed shows no prices and gives no investment advice.